|
|
40
|
|
|
4332B
|
|
|
TASIGNA 200MG CAP (NVS/COL) NILOTANIB
|
|
|
NILOTINIB
|
|
|
TASIGNA
|
|
|
112'S
|
|
|
C
|
|
|
13,233.8
|
|
|
118.16
|
|
|
200MG
|
|
|
CAPSULE
|
|
|
0
|
|
|
CAP
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|